Greenleaf Labs Issues Clarification on OMMA Recall Affecting Historical Test Batches

Mar 23, 2026

Poteau, Oklahoma — March 20, 2026 — Greenleaf Labs is providing clarification regarding the recent mandatory recall issued by the Oklahoma Medical Marijuana Authority (OMMA) for certain medical marijuana products tested between April 2023 and July 2025.

This recall is not related to any current products on the market and does not represent a new product safety concern. Instead, it is a regulatory action focused on ensuring that previously identified products were properly disposed of and fully accounted for.

“This action is about closing the loop on historical inventory,” said Chris Dooly, Managing Partner. “There is no impact to current products available to patients, and no evidence of intentional wrongdoing.”

Greenleaf Labs confirms that it remains in good standing, open, and fully operational, continuing to serve licensed operators across Oklahoma.

The OMMA’s recall follows prior regulatory actions tied to testing conducted during the specified timeframe. While a voluntary retesting process had been initiated, the recall ensures full compliance by confirming that all affected inventory has been appropriately removed from circulation.

Greenleaf Labs supports OMMA’s efforts to uphold consistency, transparency, and patient safety across Oklahoma’s medical marijuana program.

“We share OMMA’s commitment to maintaining high standards across the industry,” added Roulette Massey, Lab Director. “Our focus remains on delivering accurate testing, supporting our partners, and reinforcing trust in the regulated marketplace.”

Key Clarifications:

  • This is not a new recall or active product issue
  • Applies only to products tested between April 2023 and July 2025
  • No impact to current inventory or products on dispensary shelves
  • Action ensures proper disposal of previously identified batches
  • No evidence of intentional wrongdoing
  • Greenleaf Labs is in good standing and fully operational

Dispensaries and licensees are encouraged to review the official OMMA recall list and take any necessary action regarding affected batches.

For additional information or assistance reviewing batch data, please contact Greenleaf Labs directly. info@greenleaf-labs.com (918) 564-2760